Assessment of financial screening and navigation capabilities at National Cancer Institute community oncology clinics.
Ari Bell-Brown, Kate Watabayashi, Debbie Delaney...
https://pubmed.ncbi.nlm.nih.gov/37561111/Actively Recruiting
Led by AdventHealth · Updated on 2025-11-17
200
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are evaluating a community-based outreach program designed to improve screening, diagnosis, and treatment for breast, lung, and prostate cancers among underserved adults. The study uses the Reach, Effectiveness, Adoption, Implementation, Maintenance RE-AIM framework to understand how well the program works and its impact on cancer care in the community. The program involves identifying adults who meet cancer screening criteria and referring those with positive screening results for further diagnosis. Additionally, community stakeholders and healthcare providers are engaged through focus groups to provide feedback on the programs operations and help improve cancer screening and treatment pathways. Participants will be involved in the study from enrollment through a 3-month follow-up period, totaling 12 months. Researchers will assess aspects of the RE-AIM framework, patient health-related quality of life using the PROMIS Global Health scale, and patient satisfaction with navigation logistics. The study aims to identify barriers and facilitators to cancer care and to understand perceptions of patient navigators throughout the cancer care process.
CONDITIONS
Building on Trust: Navigating Preventive Lung, Breast, and Prostate Cancer Screenings at Community Resource Spots
P
Patricia Robinson, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
AdventHealth
Lead Sponsor
Florida Department of Health
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 12 months
Participants who undergo routine cancer screening and follow-up diagnosis are observed to identify barriers and facilitators to screening, diagnosis, and treatment.
Visits occur as needed based on screening results and follow-up referrals
Duration - Up to 12 months
Participants may engage in stakeholder focus groups to provide feedback about program operations.
1 to multiple visits depending on focus group participation
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Ari Bell-Brown, Kate Watabayashi, Debbie Delaney...
https://pubmed.ncbi.nlm.nih.gov/37561111/Adam C Carle, Pascal Jean-Pierre, Paul Winters...
https://pubmed.ncbi.nlm.nih.gov/24848207/Ron D Hays, Jakob B Bjorner, Dennis A Revicki...
https://pubmed.ncbi.nlm.nih.gov/19543809/Matthew Chen, Victoria S Wu, Derek Falk...
https://pubmed.ncbi.nlm.nih.gov/38581470/Anita J Kumar, Darcy Banco, Elise E Steinberger...
https://pubmed.ncbi.nlm.nih.gov/32160406/Jodi Summers Holtrop, Borsika A Rabin, Russell E Glasgow
https://pubmed.ncbi.nlm.nih.gov/29534729/AdventHealth
Lead Sponsor
Florida Department of Health
Collaborating Sponsor